Rituximab Completed Phase 4 Trials for Kidney Transplantation / Autoimmune Diseases Other

IndicationsStatusPurposePhase
CompletedOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT00820469Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab